
Manzi reflected on progress in the lupus field and more research to be done with anifrolumab and beyond.

Chair of the Allegheny Health Network (AHN) Medicine Institute and director of the Lupus Center of Excellence at the AHN Autoimmunity Institute

Manzi reflected on progress in the lupus field and more research to be done with anifrolumab and beyond.

Manzi discussed shifting goals to remission in the lupus field.

Manzi discussed findings from the phase 3 TULIP-SC trial of subcutaneous anifrolumab for systemic lupus erythematosus.